TrialJournal of the National Cancer Institute2023

Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.

Ryan W Huey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.